ESG rating of 82.6 with CareEdge-ESG 1+ symbol assigned by CARE ESG Ratings
CARE ESG Ratings Ltd has assigned an ESG rating to Laurus Labs on October 14, 2026.
By ScoutQuest · · 1 min read
- ESG Rating Score
- 82.6
- Rating Symbol
- CareEdge-ESG 1+
- Rating Action
- Assigned
ESG rating assigned
CARE ESG Ratings Limited, a SEBI-registered ESG Rating Provider, has assigned an ESG rating to Laurus Labs on October 14, 2026. The company has informed the stock exchanges of this under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The rating in numbers
- Rating agency: CARE ESG Ratings Ltd
- Type of rating: ESG Rating
- Rating score: 82.6
- Rating symbol: CareEdge-ESG 1+
- Rating action: Assigned
What an ESG rating is
ESG stands for Environmental, Social and Governance. An ESG rating is an outside agency's assessment of how a company manages risks and opportunities linked to these three areas, such as its environmental footprint, its practices towards employees and the community, and its governance and disclosure standards.
The update states that the rating denotes a Leadership position in managing ESG risk through best-in-class disclosures, policies and performance.
What this means for a retail investor
- This is an assessment by an external rating agency, not a financial result such as revenue, profit or an order win.
- The update records the rating action as Assigned, which means the rating has been given now.
- The two data points shared are the score of 82.6 and the symbol CareEdge-ESG 1+.
- ESG scores are used by some institutional and global investors as one of the inputs when they assess a company.
- The update gives no monetary value linked to the rating; it is a disclosure of the rating itself.
In short
The company has informed the exchanges that CARE ESG Ratings Ltd has assigned it an ESG rating with a score of 82.6 and the symbol CareEdge-ESG 1+, which the update describes as denoting a Leadership position in managing ESG risk.
Also from Laurus Labs
Laurus Labs invests INR 107.8 crore in KRKA Pharma rights issue; 49% holding unchanged
14 Oct 2026
Laurus Labs Q2 & H1 FY27 earnings conference call on October 29, 2026, hosted by DAM Capital Advisors
13 Oct 2026
Board meeting on October 29, 2026 to consider September quarter results and interim dividend proposal
13 Oct 2026
More numbers
- ESG rating score assigned by CARE ESG Ratings Ltd82.6
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.